{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.90C>T",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "C",
            "alt": "T",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutant α-Syn"
        },
        {
          "HGVS": "NM_000340.3:c.160G>A",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "G",
            "alt": "A",
            "position": "160"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T substitution"
        },
        {
          "HGVS": "NM_000340.3:c.90C>T;NM_000340.3:c.160G>A",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "C",
            "alt": "T",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "Double mutant A53T/A30P"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005095"
  },
  "Experiment Method": [
    {
      "Assay Method": "Vesicle binding assay",
      "Material used": {
        "Material Source": "Lipid vesicles",
        "Material Name": "Phospholipid vesicles",
        "Description": "Membrane interaction was assessed using lipid vesicles."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.90C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Defective membrane interaction",
          "Result Description": "A30P mutant showed significantly reduced binding to lipid vesicles compared to wild-type."
        },
        {
          "Variant": "NM_000340.3:c.160G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Defective membrane interaction",
          "Result Description": "A53T mutant exhibited impaired membrane binding compared to wild-type."
        },
        {
          "Variant": "NM_000340.3:c.90C>T;NM_000340.3:c.160G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Severe defective membrane interaction",
          "Result Description": "Double mutant A53T/A30P showed the most pronounced reduction in membrane binding."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-Syn was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal membrane binding is defined as >80% of wild-type activity.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal membrane binding is defined as <50% of wild-type activity.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}